OTC Markets OTCPK - Delayed Quote ? USD iMD Companies, Inc. (ICBU) Follow Compare 0.0053 -0.0013 (-19.70%) At close: November 15 at 3:55 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations iMD Companies and Its Subsidiary Riize Health Announce Official Product Line Launch of Riize Hair RANCHO CORDOVA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC:ICBU) and its subsidiary Riize LLC (Riize Health) is pleased to announce the launch of its Riize Hair product line. On Friday, October 25, 2024, Riize Health began selling Riize Hair, an advanced hair loss solution for men, through its telemedicine platform of licensed health care professionals. The proprietary formula in the Riize Hair products combines the most effective FDA approved prescription hair growth ing GlobeNewswire ? 10 days ago ICBU -19.70% iMD Companies and Its Subsidiary Riize Health Announce New Product Lines: Riize Hair & Riize Weight Maintenance RANCHO CORDOVA, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) subsidiary Riize, LLC (Riize Health) -- announces two new innovative products for the personal healthcare market. Riize Health will begin marketing Riize Hair, an advanced hair loss solution for men. With a proprietary formula, combining minoxidil, finasteride and biotin, the product will come in both topical solution and oral dissolving strip forms. Riize Hair will bring both a new product and treatment ap GlobeNewswire ? last month ICBU -19.70% iMD Companies and Its Subsidiary Riize, Open and Launch Telemedicine Platform in Canada RANCHO CORDOVA, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) and its subsidiary Riize, LLC (Riize Health) has completed the target expansion into the Canadian marketplace. The Riize Health telemedicine platform has officially been approved and we’re now taking orders in Canada. The platform incorporates the same pharmaceutical and medical practitioner solutions that continue to produce dynamic growth in the U.S. for its sexual wellness product lines. We’re proud to h GlobeNewswire ? last month ICBU -19.70% iMD Companies, Inc. Subsidiary Riize, LLC to Expand Product Line With Contracted Telemedicine Doctors New Products Include High Demand Hair Loss, Weight Loss, and Woman's Libido Products RANCHO CORDOVA, CA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) has completed the acquisition of Riize, LLC (Riize). As a dynamic and growing Telemedicine company, Riize will soon be expanding its products and markets, bringing additional value and growth opportunities to both companies. Riize has quickly established itself as an innovative online provider to the men's and women's personal GlobeNewswire ? 2 months ago ICBU -19.70% iMD Companies, Inc. Completes Acquisition of Riize, LLC RANCHO CARDOVA, CA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU) has completed the acquisition of Riize, LLC (Riize) and are providing more resources for Riize to leverage its product portfolio with exciting opportunities. As previously indicated, Riize is an innovative online provider to the men's and women's personal healthcare market. Riize is an innovative healthcare product developer. Riize has done a phenomenal job in less than twelve months and has seen dynamic growth GlobeNewswire ? 2 months ago ICBU -19.70% iMD Companies, Inc. Signs Letter of Intent to Acquire Healthcare Company Riize, LLC RANCHO CORDOVA, CA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC: ICBU), is proud to announce that the company has signed a Letter of Intent to acquire Riize, LLC (Riize) as a wholly owned subsidiary. iMD Companies, Inc., has officially signed a letter of intent with Riize. Riize is a revolutionary products-based telemedicine company selling into the Men’s and Women’s Sexual Health market, with products for other personal healthcare verticals being prepared to launch soon. iMD Comp GlobeNewswire ? 2 months ago ICBU -19.70% Performance Overview Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return ICBU S&P 500 YTD +1,225.00% +23.08% 1-Year +960.00% +30.58% 3-Year +47.22% +25.36%
